Works matching IS 15257304 AND DT 2022 AND VI 23 AND IP 4

Results: 9

A Lung Cancer Screening Education Program Impacts both Referral Rates and Provider and Medical Assistant Knowledge at Two Federally Qualified Health Centers.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 4, p. 356, doi. 10.1016/j.cllc.2021.12.002

By:

Akhtar, Aamna;
Sosa, Ernesto;
Castro, Samuel;
Sur, Melissa;
Lozano, Vanessa;
D'Souza, Gail;
Yeung, Sophia;
Macalintal, Jonjon;
Patel, Meghna;
Xiaoke Zou;
Pei-chi Wu;
Silver, Ellen;
Sandoval, Jossie;
Gray, Stacy W.;
Reckamp, Karen L.;
Jae Y. Kim;
Sun, Virginia;
Raz, Dan J.;
Erhunmwunsee, Loretta

Publication type:

Article

Corrigendum to "Docetaxel downregulates PD-1 expression via STAT3 in Tlymphocytes" [Clinical Lung Cancer 19 (2018) e675-e683].

Published in:: Clinical Lung Cancer, 2022, v. 23, n. 4, p. 374, doi. 10.1016/j.cllc.2022.03.004
Publication type:: Article

Real-world Treatment Patterns and Outcomes in Stage III Non-small Cell Lung Cancer: Middle East and Africa -- KINDLE Study.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 4, p. 364, doi. 10.1016/j.cllc.2022.02.002

By:

Jazieh, A. R.;
Sağlam, E. Kaytan;
Önal, H. C.;
Abdelkader, Y.;
Gaafar, R.;
Dawoud, E.;
Nassar, M.;
Alshorbagy, D.;
El Ashry, H.;
Elsayed, M.

Publication type:

Article

Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 4, p. 345, doi. 10.1016/j.cllc.2021.12.010

By:

Yizhen Guo;
Lai Wei;
Patel, Sandip H.;
Lopez, Gabrielle;
Grogan, Madison;
Mingjia Li;
Haddad, Tyler;
Johns, Andrew;
Ganesan, Latha P.;
Yiping Yang;
Spakowicz, Daniel J.;
Shields, Peter G.;
Kai He;
Bertino, Erin M.;
Otterson, Gregory A.;
Carbone, David P.;
Presley, Carolyn;
Kulp, Samuel K.;
Mace, Thomas A.;
Coss, Christopher C.

Publication type:

Article

Controversies in Lung Cancer: Heterogeneity in Treatment Recommendations for Stage III NSCLC According to Disease Burden and Oncogenic Driver Alterations.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 4, p. 333, doi. 10.1016/j.cllc.2022.02.001

By:

Harris, Jeremy P.;
Fujimoto, Dylann K.;
Misako Nagasaka;
Ku, Eric;
Harada, Garrett;
Keshava, Hari;
Mahtabifard, Ali;
Longoria, Javier;
Patel, Niral;
Seyedin, Steven;
Simon, Aaron;
Chen, Allen

Publication type:

Article

Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 4, p. 320, doi. 10.1016/j.cllc.2022.03.002

By:

Veillon, Remi;
Hiroshi Sakai;
Xiuning Le;
Felip, Enriqueta;
Cortot, Alexis B.;
Smit, Egbert E.;
Keunchil Park;
Griesinger, Frank;
Britschgi, Christian;
Yi-Long Wu;
Melosky, Barbara;
Baijal, Shobhit;
de Castro Jr., Gilberto;
Sedova, Michaela;
Berghoff, Karin;
Otto, Gordon;
Paik, Paul K.

Publication type:

Article

Molecular Characteristics of the Uncommon EGFR Exon 21 T854A Mutation and Response to Osimertinib in Patients With Non-Small Cell Lung Cancer.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 4, p. 311, doi. 10.1016/j.cllc.2021.12.008

By:

Lihong Zhang;
Xia Yang;
Zongjuan Ming;
Jie Shi;
Xin Lv;
Wei Li;
Bo Yuan;
Yang Chen;
Boxuan Liu;
Kai Qin;
Jiamin Liu;
Qingbo Wei;
Dejian Gu;
Rongrong Chen;
Mingming Yuan;
Cui, Jean;
Sai-Hong Ignatius Ou;
Shuanying Yang

Publication type:

Article

A Randomized, Open-Label Phase II Study Evaluating Emibetuzumab Plus Erlotinib and Emibetuzumab Monotherapy in MET Immunohistochemistry Positive NSCLC Patients with Acquired Resistance to Erlotinib.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 4, p. 300, doi. 10.1016/j.cllc.2022.03.003

By:

Camidge, D. Ross;
Moran, Teresa;
Demedts, Ingel;
Grosch, Heidrun;
Mileham, Kathryn;
Molina, Julian;
Juan-Vidal, Oscar;
Bepler, Gerold;
Goldman, Jonathan W.;
Keunchil Park;
Wallin, Johan;
Wijayawardana, Sameera R.;
Xuejing Aimee Wang;
Wacheck, Volker;
Smit, Egbert

Publication type:

Article

Disease Burden on PET Predicts Outcomes for Advanced NSCLC Patients Treated with First-Line Immunotherapy.

Published in:

Clinical Lung Cancer, 2022, v. 23, n. 4, p. 291, doi. 10.1016/j.cllc.2022.02.003

By:

Andraos, Therese Y.;
Halmos, Balazs;
Haiying Cheng;
Huntzinger, Calvin;
Shirvani, Shervin M.;
Ohri, Nitin

Publication type:

Article